Late gadolinium enhancement as a potential marker of increased perioperative risk in aortic valve replacement

Interactive Cardiovascular and Thoracic Surgery

Volumn 15, Issue 1, 2012, Pages 45-50

  Quarto, Cesare ^a   Dweck, Marc R ^a,b   Murigu, Timothy ^a   Joshi, Sanjiv ^a   Melina, Giovanni ^a   Angeloni, Emiliano ^a   Prasad, Sanjay K ^a   Pepper, John R ^a  

^a ROYAL BROMPTON HOSPITAL   (United Kingdom)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

Aortic valve stenosis; Magnetic resonance; Myocardial fibrosis; Risk assessment

Indexed keywords

GADOLINIUM; GADOLINIUM PENTETATE;

ADULT; AGED; AORTA STENOSIS; AORTA VALVE REPLACEMENT; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MAGNETIC RESONANCE; CEREBROVASCULAR ACCIDENT; CEREBROVASCULAR DISEASE; CONTRAST ENHANCEMENT; CORONARY ARTERY BYPASS SURGERY; FEMALE; FOLLOW UP; HEART BLOCK; HEART INFARCTION; HEART LEFT VENTRICLE MASS; HEART LEFT VENTRICLE VOLUME; HEART LEFT VENTRICLE WALL; HEART VENTRICLE TACHYCARDIA; HUMAN; LATE GADOLINIUM ENHANCEMENT; MAJOR CLINICAL STUDY; MALE; MORTALITY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME;

AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; AORTIC VALVE STENOSIS; CEREBROVASCULAR DISORDERS; CHI-SQUARE DISTRIBUTION; CONTRAST MEDIA; FEMALE; FIBROSIS; GADOLINIUM DTPA; HEART BLOCK; HEART VALVE PROSTHESIS IMPLANTATION; HUMANS; LONDON; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TREATMENT OUTCOME;

EID: 84863471590     PISSN: 15699293     EISSN: 15699285     Source Type: Journal    
DOI: 10.1093/icvts/ivs098     Document Type: Article

References (14)

1. Bonow RO, Carabello BA, Chatterjee K, de Leon AC Jr, Faxon DP, Freed MD et al. Acc/aha 2006 guidelines for the management of patients with valvular heart disease: a report of the american college of cardiology/ american heart association task force on practice guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the society of cardiovascular anesthesiologists endorsed by the society for cardiovascular angiography and interventions and the society of thoracic surgeons. J Am Coll Cardiol 2006;48:e1-148.
2. Bridgewater B, Keogh B, Kinsman R, Walton P. The society for cardiothoracic surgery in great britain and ireland, sixth national adult cardiac surgical data base report 2008. Dendrite clinical system ltd. 2009;164-73.
3. Morris JJ, Schaff HV, Mullany CJ, Morris PB, Frye RL, Orszulak TA. Gender differences in left ventricular functional response to aortic valve replacement. Circulation 1994;90:II183-9.
4. Cioffi G, Faggiano P, Vizzardi E, Tarantini L, Cramariuc D, Gerdts E et al. Prognostic effect of inappropriately high left ventricular mass in asymptomatic severe aortic stenosis. Heart 2011;97:301-7.
5. Gosse P. Left ventricular hypertrophy as a predictor of cardiovascular risk. J Hypertens Suppl 2005;23:S27-33.
6. Debl K, Djavidani B, Buchner S, Lipke C, Nitz W, Feuerbach S et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 2006;92:1447-51.
7. Rudolph A, Abdel-Aty H, Bohl S, Boye P, Zagrosek A, Dietz R et al. Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy relation to remodeling. J Am Coll Cardiol 2009;53:284-91.
8. Dweck MR, Joshi S, Murigu T, Alpendurada F, Jabbour A, Melina G et al. Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis. J Am Coll Cardiol 2011;58:1271-9.
9. Assomull RG, Prasad SK, Lyne J, Smith G, Burman ED, Khan M et al. Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006;48:1977-85.
10. Friedrich M, Schulz-Menger J, Dietz R. Magnetic resonance to assess the aortic valve area in aortic stenosis. J Am Coll Cardiol 2004;43:2148, author reply 2148-9.
11. O'Hanlon R, Grasso A, Roughton M, Moon JC, Clark S, Wage R et al. Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 2010;56:867-74.
12. Kwong RY, Chan A, Brown KA, Chan CW, Reynolds HG, Tsang S et al. Impact of unrecognized myocardial scar detected by cardiac magnetic resonance imaging on event-free survival in patients presenting with signs or symptoms of coronary artery disease. Circulation 2006;113:2733-43.
13. Nazarian S. Is ventricular arrhythmia a possible mediator of the association between aortic stenosis-related midwall fibrosis and mortality? J Am Coll Cardiol 2011;58:1280-2.
14. Hein S, Arnon E, Kostin S, Schonburg M, Elsasser A, Polyakova V et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003;107:984-91.